Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study

被引：0
|
作者：
Liang Qiao
Shun Lv
Kai Meng
Jianmei Yang
机构：
[1] Shanghai Xuhui District Central Hospital,
来源：
Clinical Rheumatology | 2024年 / 43卷
关键词：
eQTL; Lipid-lowering drugs; Mendelian randomization; Rheumatoid arthritis; SMR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：939 / 947
页数：8
相关论文
共 50 条
  • [1] Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study
    Qiao, Liang
    Lv, Shun
    Meng, Kai
    Yang, Jianmei
    [J]. CLINICAL RHEUMATOLOGY, 2024, 43 (03) : 1063 - 1071
  • [2] Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study
    Liu, Luyang
    Sheng, Chao
    Lyu, Zhangyan
    Dai, Hongji
    Chen, Kexin
    [J]. FRONTIERS IN NUTRITION, 2021, 8
  • [3] Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study
    Yan, Zhaoqi
    Xu, Yifeng
    Li, Keke
    Liu, Liangji
    [J]. ACTA NEUROLOGICA BELGICA, 2024, 124 (02) : 485 - 494
  • [4] Association between genetically proxied lipid-lowering drug targets, lipid traits, and amyotrophic lateral sclerosis: a mendelian randomization study
    Zhaoqi Yan
    Yifeng Xu
    Keke Li
    Liangji Liu
    [J]. Acta Neurologica Belgica, 2024, 124 : 485 - 494
  • [5] Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study
    He, Jing-Yang
    Zhang, Xue
    Wang, Kui
    Lv, Wan-Qiang
    [J]. JOURNAL OF NUTRITION, 2022, 152 (05): : 1283 - 1290
  • [6] Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
    Yarmolinsky, James
    Diez-Obrero, Virginia
    Richardson, Tom M.
    Pigeyre, Marie E.
    Sjaarda, Jennifer Y.
    Pare, Guillaume
    Walker, Venexia
    Vincent, Emma
    Tan, Vanessa
    Obon-Santacana, Mireia
    Albanes, Demetrius K.
    Hampe, Jochen
    Gsur, Andrea
    Hampel, Heather
    Pai, Rish
    Jenkins, Mark I.
    Gallinger, Steven
    Casey, Graham M.
    Zheng, Wei
    Amos, Christopher
    Smith, George Davey
    Martin, Richard
    Moreno, Victor
    PRACTICAL consortium
    MEGASTROKE consortium
    [J]. PLOS MEDICINE, 2022, 19 (02)
  • [7] Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization Study
    Soremekun, Opeyemi
    Mhlongwe, Thobeka
    Kirabo, Gloria
    Akinyele, Callistus
    Chikowore, Tinashe
    Fatumo, Segun
    Gill, Dipender
    [J]. STROKE, 2024, 55 (07) : e185 - e186
  • [8] Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
    Xiao, Wendi
    Li, Yueying
    Zhuang, Zhenhuang
    Song, Zimin
    Wang, Wenxiu
    Huang, Ninghao
    Dong, Xue
    Jia, Jinzhu
    Liu, Zhonghua
    Zhao, Yimin
    Qi, Lu
    Huang, Tao
    [J]. LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [9] GENETICALLY PROXIED THERAPEUTIC INHIBITION OF ANTIHYPERTENSIVE DRUG TARGETS AND RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION ANALYSIS
    Song, S.
    Wang, C.
    Zhao, R.
    Qiao, J.
    Zhang, S. X.
    Li, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1067 - 1067
  • [10] Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
    Miao, Lusheng
    Miao, Taosheng
    Zhang, Ying
    Hao, Jin
    [J]. BMC CANCER, 2024, 24 (01)
12345